Clinical Trial

The Mauritius and Rodrigues Non-Communicable Disease (NCD) Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Mauritius is located in the southern Indian Ocean with a population of 1.3 million in 2023. Mauritius is a multiethnic nation with 68% South Asian, 27% African (Creole), 3% Chinese and 2% Franco Mauritians. Seven population-based cross-sectional surveys using standardised protocols were conducted between 1987 and 2021). The participation rate has been over 85% in each survey. At each survey, participants were interviewed about living conditions, lifestyle and health, and anthropometry and blood pressure were measured. Biochemistry including lipids and an oral glucose tolerance test (OGTT) were performed Electrocardiograms (ECG) were recorded in participants aged 35 years and older. Previous participants were followed up in 2007 and 92% were successfully traced. Studies with identical methodology have been performed on the neighbouring island Rodrigues where the majority of the population are Creoles.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-24.
Trial Details
NCT Number NCT07048717
Lead Sponsor Umeå University
Collaborators: Ministry of Health and Wellness, Mauritius, University of Helsinki, Monash University, Imperial College London, Baker Heart and Diabetes Institute
Conditions Diabete Mellitus, Cardiovascular Disease Risk Factor, Ischemic Cardiovascular Disease, Hypertension, Obesity & Overweight
Enrollment 39,082 participants
Start Date 1987-04-05
Primary Completion 2021-11-23 (estimated)
Study Completion 2050-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-17